China's National Health Commission Mandates Labor Pain Management Services Expansion
Policy / Regulatory

China’s National Health Commission Mandates Labor Pain Management Services Expansion

Intragrand Pharma Licenses Lenamilast to Transpire Bio for Global Development
CompanyDeals

Intragrand Pharma Licenses Lenamilast to Transpire Bio for Global Development

Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D
CompanyDeals

Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D

Innovent Biologics' IBI363 Receives Breakthrough Therapy Designation from CDE
CompanyDrug

Innovent Biologics’ IBI363 Receives Breakthrough Therapy Designation from CDE

BMS Secures NMPA Approval for Reblozyl in Myelodysplastic Syndromes
CompanyDrug

BMS Secures NMPA Approval for Reblozyl in Myelodysplastic Syndromes

Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products
CompanyDeals

Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products

Genrix Bio Partners with Cullinan Therapeutics for GR1803 License
CompanyDeals

Genrix Bio Partners with Cullinan Therapeutics for GR1803 License

AstraZeneca's Imfinzi Approved for Limited Stage Small Cell Lung Cancer in China
CompanyDrug

AstraZeneca’s Imfinzi Approved for Limited Stage Small Cell Lung Cancer in China

Akeso Biopharma Wins NMPA Approval for New Cadonilimab Indication
CompanyDrug

Akeso Biopharma Wins NMPA Approval for New Cadonilimab Indication

Salubris Pharmaceuticals' Allisartan-Indapamide Hybrid Wins NMPA Approval
CompanyDrug

Salubris Pharmaceuticals’ Allisartan-Indapamide Hybrid Wins NMPA Approval

Wantai Biopharm's Cecolin 9 HPV Vaccine Approved by China's NMPA
CompanyDrug

Wantai Biopharm’s Cecolin 9 HPV Vaccine Approved by China’s NMPA

Biocytogen and Chia Tai Tianqing Win NMPA Approval for NTB003 Clinical Trials
CompanyDrug

Biocytogen and Chia Tai Tianqing Win NMPA Approval for NTB003 Clinical Trials